Schedule 13D ownership disclosure
CATABASIS PHARMACEUTICALS IN
Security class unavailable · CUSIP: 14875P206
Event date: 2021-06-08
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-21-200532
- Form type
- SC 13D
- Filer
- Astria Therapeutics, Inc.
- CIK
- CIK 1454789
- Filed
- Jun 25, 2021
- Reporting period
- Jun 08, 2021
- Description
- Schedule 13D beneficial ownership